Nevro (NVRO) : Mondays money flow indicated an uptick to downtick ratio was at 3.39. The total value of inflow transactions on upticks was $5.49 million, whereas, the total value of outflow trades on downticks was $1.62 million. The total money flow was $3.87 million, which shows a mild bullish bias. The total money flow into the stock in block trades was $4.33 million. The total value of the trades done on upticks was $4.33 million. Nevro (NVRO) was trading with a -0.9% change over previous days close. It fell $0.89 during the day and reached $97.01. The stock was 20.46% compared to the previous weeks close.
Shares of Nevro Corp. rose by 20.48% in the last five trading days and 21.2% for the last 4 weeks. Nevro Corp. is up 50.1% in the last 3-month period. Year-to-Date the stock performance stands at 44.45%.
Nevro (NYSE:NVRO): The stock opened at $97.73 on Monday but the bulls could not build on the opening and the stock topped out at $98.91 for the day. The stock traded down to $96.52 during the day, due to lack of any buying support eventually closed down at $97.52 with a loss of -0.38% for the day. The stock had closed at $97.89 on the previous day. The total traded volume was 793,448 shares.
In a related news, The officer (VP, Quality), of Nevro Corp, Alleavitch Doug had unloaded 2,500 shares at $95 per share in a transaction on August 10, 2016. The total value of transaction was $237,500. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Nevro Corp. is a medical device company. The Company manufactures and markets active implantable medical devices for the treatment of neurological disorders initially focusing on the treatment of chronic pain. The Company developed and commercialized a neuromodulation platform for the treatment of chronic pain. The Companys Senza system is the only spinal cord stimulation (SCS) system that delivers its HF10 therapy. The Companys Senza system creates electrical impulses from two hertz to 10 kilohertz, including its HF10 therapy, which allows for pain relief without paresthesia. HF10 therapy delivers waveforms at 10 kilohertz pulse rate with a statistically driven and clinically verified programming algorithm. Senza consists of leads, a trial stimulator, an implantable pulse generator (IPG), surgical tools, a clinician laptop programmer, a patient remote control and a mobile charger.